SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Targanta Therapeutics Corp. – IPO: ‘S-1’ on 5/11/07 – EX-10.7.1

On:  Friday, 5/11/07, at 12:00pm ET   ·   Accession #:  1193125-7-111369   ·   File #:  333-142842

Previous ‘S-1’:  None   ·   Next:  ‘S-1/A’ on 6/27/07   ·   Latest:  ‘S-1/A’ on 10/5/07   ·   2 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 5/11/07  Targanta Therapeutics Corp.       S-1                   22:3.4M                                   RR Donnelley/FA

Initial Public Offering (IPO):  Registration Statement (General Form)   —   Form S-1
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-1         Registration Statement (General Form)               HTML   1.86M 
 2: EX-3.1      2nd Amended & Restated Certificate of               HTML    113K 
                          Incorporation                                          
 3: EX-4.2      Amended & Restated Registration Rights Agreement    HTML    114K 
 4: EX-10.1     2005 Stock Option Plan, as Amended                  HTML     80K 
 5: EX-10.1.1   Form of Notice of Stock Option Grant                HTML     20K 
 6: EX-10.1.2   Form of Stock Option Agreement                      HTML     24K 
 7: EX-10.1.3   Form of Notice of Stock Option Grant for Montreal   HTML     22K 
                          Employees                                              
 8: EX-10.1.4   Form of Stock Option Agreement for Montreal         HTML     24K 
                          Employees                                              
13: EX-10.12    Asset Purchase Agreement                            HTML    172K 
14: EX-10.13    Note Issuance Agreement                             HTML    141K 
15: EX-10.14    Senior Secured Convertible Acquisition Note         HTML     35K 
16: EX-10.15    Omnibus Amendment to Asset Purchase Agreement       HTML     36K 
17: EX-10.17    Form of Indemnification Agreement                   HTML     64K 
18: EX-10.18    Form of Employee Agreement Re: Non-Competition,     HTML     35K 
                          Non-Solicitation                                       
19: EX-10.19    Form of Series C-1 Preferred Stock Warrant          HTML     76K 
20: EX-10.20    Form of Common Stock Warrant                        HTML     76K 
 9: EX-10.3     Employment Agreement With Mark Leuchtenberger       HTML     53K 
10: EX-10.4     Employee Agreement With George Eldridge             HTML     53K 
11: EX-10.7     Lease Agreement With American Twine Ltd.            HTML    202K 
                          Partnership                                            
12: EX-10.7.1   1st Amendment to Lease With American Twine Ltd.     HTML     23K 
                          Partnership                                            
21: EX-21.1     List of Subsidiaries                                HTML      9K 
22: EX-23.2     Consent of Ernst & Young LLP                        HTML     10K 


EX-10.7.1   —   1st Amendment to Lease With American Twine Ltd. Partnership


This exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



  1st Amendment to Lease with American Twine Ltd. Partnership  

Exhibit 10.7.1

First Amendment to Lease

First Amendment made this 4th day of May, 2007 by and between Targanta Therapeutics Corporation (“Tenant”) and American Twine Limited Partnership (“Landlord”)

WITNESSETH THAT

WHEREAS the parties have heretofore entered into a lease dated October 20, 2006 (the “Lease”).

WHEREAS the Tenant wishes to expand the Premises demised under the Lease to include suite 1200, which contains 1,471 rentable square feet located on the first floor of the Building (as shown on Exhibit A attached) ( the “Expansion Space”) and to extend the lease term.

NOW THEREFORE, for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereby agree as follows:

 

  1. The effective date of this First Amendment shall be the Commencement Date as defined in item 8 below.

 

  2. Effective after the effective date, the information contained in Section 1.1 of the Lease immediately following the Heading “Premises” is amended to add Suite 1200, 1,471 rsf

 

  3. The information following contained in Section 1.1 of the Lease immediately following the heading Term is deleted in its entirety and replaced with “Expires October 31, 2009.

 

  4. Effective after the effective date, the information following the contained in Section 1.1 of the Lease immediately following the heading Tenant’s Prorate Share is amended to add the Pro Rata share for the Expansion Space, which is 1.27%. The total Pro Rata share will be 5.31%

 

  5. The information contained in Section 1.1 of the Lease immediately following the heading Parking Spaces is amended to add one (1) additional parking space for suite 1200 at $150.00 per month. Total number of parking spaces shall be four (4).

 

  6. Effective after the effective date, the information contained in Section 1 of the Lease, immediately following the heading Annual Fixed Rent is deleted in its entirety and the following is substituted:

 

The Annual fixed Rent for the Expansion Space shall be as follows:

  

For the first year following the Commencement

  

Date of First Amendment:

   $46,866.06

From the First anniversary of Commencement Dateof the First Amendment until

October 31, 2009

   $48,337.06

The Annual Fixed Rent for the existing space shall be as follows:

  

From Commencement Date of First Amendment through October 31, 2008:

   $142,084.80

November 1, 2008October 31, 2009

   $153,784.80


  7. The Security Deposit under the Lease as amended to add $7,232.00 for a total of $39,992.00.

 

  8. The effective date and Commencement Date of this First Amendment shall be the earlier to occur of: (a) two (2) business days after Tenant receives written notice from Landlord of the date that Landlord’s Work as defined in Exhibit B has been substantially completed and delivery of possession of the Expansion Space; or (b) the date of occupancy of the Premises by Tenant for the conduct of Tenant’s business, and shall continue for the Term, as amended, unless sooner terminated as provided in the Lease. The term “substantially completed,” as used herein, shall mean that the Landlord’s Work has been completed with the exception of minor items which can be fully completed without material interference with Tenant and other items which because of the season or weather or the nature of the item are not practicable to do at the time, provided that none of said items is necessary to make the Premises tenantable for the Permitted Uses. Tenant shall provide a list of punch list items for Landlord’s Work within thirty (30) days of occupancy of the Expansion Space.

 

  9. Tenant retains its option to extend the term of the Lease as amended for two (2) periods of one (1) year each as defined in the Lease.

 

  10. Tenant represents and warrants the Tenant has had no contact with any broker in connection with this First Amendment. Landlord represents and warrants the Landlord has had no contact with any broker in connection with this First Amendment. Landlord and Tenant will each indemnify and hold the other harmless in the event that any other broker claims a commission from Landlord as a result of representing Tenant or from Tenant as a result of representing Landlord.
  11. Landlord represents that, as of the date hereof, Tenant is not in default under the Lease, and that the Lease is in full force and effect.

Except as herein provided the terms and conditions of the Lease shall remain in full force and effect. Executed as a sealed instrument as of the day and year first above written.

 

LANDLORD:     TENANT:
American Twine Limited Partnership Anthony Goschalk       Targanta Therapeutics Corporation
ATLP, Inc., Its General Partner      
By:  

/s/ Anthony Goschalk

    By:  

/s/ George Eldridge

Name:   Anthony Goschalk     Name:   George Eldridge
Title:   President     Title:   Chief Financial Officer

 

2


Dates Referenced Herein

This ‘S-1’ Filing    Date    Other Filings
10/31/09None on these Dates
11/1/08
10/31/08
Filed on:5/11/07
10/20/06
 List all Filings 


2 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 7/09/07  SEC                               UPLOAD10/06/17    1:42K  Targanta Therapeutics Corp.
 6/06/07  SEC                               UPLOAD10/06/17    1:55K  Targanta Therapeutics Corp.
Top
Filing Submission 0001193125-07-111369   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., Apr. 25, 7:08:15.1pm ET